L d'Agay-Abensour - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

European Journal of Clinical Pharmacology|January 1, 1996

Bioavailability of 1-deamino-8-D-arginine vasopressin with an enzyme inhibitor (aprotinin) from the small intestine in healthy volunteersA Fjellestad-Paulsen, L d'Agay-Abensour, P Höglund, et al.

European Journal of Clinical Pharmacology|January 1, 1993

Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in manL d'Agay-Abensour, A Fjellestad-Paulsen, P Höglund, et al.

The Journal of Nutrition|March 1, 1997

Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humansY Bouhnik, B Flourié, L D'Agay-Abensour, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

European Journal of Clinical Pharmacology|January 1, 1996

Bioavailability of 1-deamino-8-D-arginine vasopressin with an enzyme inhibitor (aprotinin) from the small intestine in healthy volunteersA Fjellestad-Paulsen, L d'Agay-Abensour, P Höglund, et al.

European Journal of Clinical Pharmacology|January 1, 1993

Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in manL d'Agay-Abensour, A Fjellestad-Paulsen, P Höglund, et al.

The Journal of Nutrition|March 1, 1997

Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humansY Bouhnik, B Flourié, L D'Agay-Abensour, et al.

Pageof 1